Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-26 Purchase | 2024-03-28 4:08 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 12,100 | $5.267 | $63,731 | 639,200 (Direct) | View |
| 2023-12-07 Purchase | 2023-12-08 4:05 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 1,600 | $4.1 | $6,560 | 627,100 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-20 9:59 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 590 | $2.35 | $1,387 | 590 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-17 Option Award | 2023-11-21 4:21 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 624,910 | $0 | 625,500 (Direct) | View |
| 2023-07-18 Option Award | 2023-07-20 4:15 pm | N/A 2032-10-16 | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 1,011,826 | $0 | 1,011,826 (Direct) | View |
| 2023-07-18 Disposition | 2023-07-20 4:15 pm | N/A 2032-10-16 | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 1,011,826 | $0 | 1,011,826 (Direct) | View |
Ownership | 2023-07-13 9:01 pm | N/A 2032-10-16 | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 0 | $0 | 1,011,826 (Direct) | View |